Skip Header

 

1 - 25 of 48 results for author:"Kaji H."Drop in Literature Citations

Customize display Download...

Page of 2 | Next »

Difference between Japanese and Caucasian populations in the allelic frequency of growth hormone receptor polymorphisms.

Iida K., Takahashi Y., Kaji H., Okimura Y., Nose O., Chihara K.

J. Pediatr. Endocrinol. Metab. 22:41-46(2009) · Mapped (5)

Identification and analysis of prophet of Pit-1-binding sites in human Pit-1 gene.

Ikeshita N., Kawagishi M., Shibahara H., Toda K., Yamashita T., Yamamoto D., Sugiyama Y., Iguchi G., Iida K., Takahashi Y. et al.

Endocrinology 149:5491-5499(2008) · Mapped (5)

Branched-chain amino acids and arginine suppress MaFbx/atrogin-1 mRNA expression via mTOR pathway in C2C12 cell line.

Herningtyas E.H., Okimura Y., Handayaningsih A.E., Yamamoto D., Maki T., Iida K., Takahashi Y., Kaji H., Chihara K.

Biochim. Biophys. Acta 1780:1115-1120(2008) · Mapped (6)

Mannose-binding lectin gene polymorphisms and the development of coal workers' pneumoconiosis in Japan.

Wang X., Ohtsuka Y., Kimura K., Kaji H., Saito J., Tanino Y., Ishida T., Munakata M.

Am. J. Ind. Med. 51:548-553(2008) · Mapped (3)

Genetic variations at the CCAAT/enhancer-binding protein delta are associated with metabolic phenotypes in the Japanese population.

Kaji H., Fukano C., Kimura Y., Takiguchi E., Tanida K.

Metab Syndr Relat Disord 6:24-31(2008) · Mapped (2)

Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes.

Takahashi M., Takahashi Y., Takahashi K., Zolotaryov F.N., Hong K.S., Kitazawa R., Iida K., Okimura Y., Kaji H., Kitazawa S. et al.

FEBS Lett. 582:573-578(2008) · Mapped (2)

CXCL14 enhances insulin-dependent glucose uptake in adipocytes and is related to high-fat diet-induced obesity.

Takahashi M., Takahashi Y., Takahashi K., Zolotaryov F.N., Hong K.S., Iida K., Okimura Y., Kaji H., Chihara K.

Biochem. Biophys. Res. Commun. 364:1037-1042(2007) · Mapped (5)

Involvement of mPOU (Brn-5), a class VI POU protein, in the gene expression of Pit-1 as well as PRL.

Toda K., Yamamoto D., Fumoto M., Ikeshita N., Herningtyas E.H., Iida K., Takahashi Y., Kaji H., Chihara K., Okimura Y.

Mol. Cell. Endocrinol. 280:20-29(2008) · Mapped (3)

Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis elegans and suggests an atypical translocation mechanism for integral membrane proteins.

Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T., Taoka M., Takahashi N., Isobe T.

Mol. Cell. Proteomics 6:2100-2109(2007) · UniProtKB (759)

Structural basis for aminoglycoside inhibition of bacterial ribosome recycling.

Borovinskaya M.A., Pai R.D., Zhang W., Schuwirth B.S., Holton J.M., Hirokawa G., Kaji H., Kaji A., Cate J.H.

Nat. Struct. Mol. Biol. 14:727-732(2007) · Mapped (50)

Novel activity of eukaryotic translocase, eEF2: dissociation of the 80S ribosome into subunits with ATP but not with GTP.

Demeshkina N., Hirokawa G., Kaji A., Kaji H.

Nucleic Acids Res. 35:4597-4607(2007) · Mapped (2)

Smad3 differently affects osteoblast differentiation depending upon its differentiation stage.

Kaji H., Naito J., Sowa H., Sugimoto T., Chihara K.

Horm. Metab. Res. 38:740-745(2006) · Mapped (6)

Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblastic cells.

Tobimatsu T., Kaji H., Sowa H., Naito J., Canaff L., Hendy G.N., Sugimoto T., Chihara K.

Endocrinology 147:2583-2590(2006) · Mapped (15)

Processing of amyloid beta-peptides by neutral cysteine protease bleomycin hydrolase.

Kajiya A., Kaji H., Isobe T., Takeda A.

Protein Pept. Lett. 13:119-123(2006) · Mapped (2)

The role of ribosome recycling factor in dissociation of 70S ribosomes into subunits.

Hirokawa G., Nijman R.M., Raj V.S., Kaji H., Igarashi K., Kaji A.

RNA 11:1317-1328(2005) · Mapped (1)

Menin suppresses osteoblast differentiation by antagonizing the AP-1 factor, JunD.

Naito J., Kaji H., Sowa H., Hendy G.N., Sugimoto T., Chihara K.

J. Biol. Chem. 280:4785-4791(2005) · Mapped (22)

Involvement of calcium-sensing receptor in osteoblastic differentiation of mouse MC3T3-E1 cells.

Yamauchi M., Yamaguchi T., Kaji H., Sugimoto T., Chihara K.

Am. J. Physiol. Endocrinol. Metab. 288:E608-16(2005) · Mapped (3)

Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.

Sowa H., Kaji H., Hendy G.N., Canaff L., Komori T., Sugimoto T., Chihara K.

J. Biol. Chem. 279:40267-40275(2004) · Mapped (48)

Menin inactivation leads to loss of transforming growth factor beta inhibition of parathyroid cell proliferation and parathyroid hormone secretion.

Sowa H., Kaji H., Kitazawa R., Kitazawa S., Tsukamoto T., Yano S., Tsukada T., Canaff L., Hendy G.N., Sugimoto T. et al.

Cancer Res. 64:2222-2228(2004) · Mapped (12)

A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred.

Iida K., Okimura Y., Takahashi K., Inomata S., Iguchi G., Kaji H., Chihara K.

Int. J. Mol. Med. 13:401-404(2004) · Mapped (2)

Diverse regulation of full-length and truncated growth hormone receptor expression in 3T3-L1 adipocytes.

Iida K., Takahashi Y., Kaji H., Yoshioka S., Murata M., Iguchi G., Okimura Y., Chihara K.

Mol. Cell. Endocrinol. 210:21-29(2003) · Mapped (5)

Parathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblasts.

Sowa H., Kaji H., Iu M.F., Tsukamoto T., Sugimoto T., Chihara K.

J. Biol. Chem. 278:52240-52252(2003) · Mapped (9)

Temperature-sensitive mutation in yeast mitochondrial ribosome recycling factor (RRF).

Teyssier E., Hirokawa G., Tretiakova A., Jameson B., Kaji A., Kaji H.

Nucleic Acids Res. 31:4218-4226(2003) · UniProtKB (1)

Structural comparison between wild-type and P25S human cystatin A by NMR spectroscopy. Does this mutation affect the alpha-helix conformation?

Shimba N., Kariya E., Tate S., Kaji H., Kainosho M.

J. Struct. Funct. Genomics 1:26-42(2000) · Mapped (1)

The R271W mutant form of Pit-1 does not act as a dominant inhibitor of Pit-1 action to activate the promoters of GH and prolactin genes.

Kishimoto M., Okimura Y., Fumoto M., Iguchi G., Iida K., Kaji H., Chihara K.

Eur. J. Endocrinol. 148:619-625(2003) · Mapped (2)

Page of 2 | Next »